Company intelligence / Profile preview

Kuehnle AgroSystems

Honolulu, Hawaii, United States

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Kuehnle AgroSystems has developed a proprietary dark fermentation platform enabling rapid, cost-effective production of natural astaxanthin from non-GMO microalgae. Their strategic partnership with Corbion aims to deliver highly bioavailable, stable, and esterified astaxanthin for both human health and aquaculture applications. The company is preparing for large-scale commercialization in partnership with European production and plans further distribution globally.

Therapeutic areas: OtherDermatology
Modalities: Small moleculeNatural extractFermentation-based bioproducts
Industry: Non-Drug Biotech

Partnerships

Corbion (strategic partner for industrial scale production and commercialization of astaxanthin)European production partner (contract manufacturing for initial launch)

Beyond the preview

Go deeper on Kuehnle AgroSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kuehnle AgroSystems.

Explore the full profile